OS Therapies Incorporated ( OSTX ) IPO will take place June, 21 on the NYSE exchange under the ticker OSTX.

The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on December 18, 2024.

See also: Benzinga IPO Calendar

About OS Therapies Incorporated

OS Therapies Incorporated ( OSTX ) is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.